The approved building blocks

Every component the AI can use. Nothing else exists.

Hero

Approved Hero

Advancing breakthroughs that change patients' lives

A governed component system for regulated web experiences, with built-in evidence structure and compliance-ready content patterns.

Review the evidence

Compliance framing

Every visual choice here maps back to approved tokens and constrained component definitions.

SectionHeader

Our Medicines

A fictional data set rendered through the approved pharma component vocabulary.

ContentBlock

Apexa is a fictional treatment used here to demonstrate how structured content, evidence references, and market-specific disclosures can all sit inside a constrained component model.

Card

Fast specialist onboarding

Guide HCP audiences from core mechanism-of-action content to evidence modules without leaving the approved component set.

View pathway

Card

Modular fair-balance sections

Generate multiple compliant variants while keeping safety, references, and disclosure surfaces structurally mandatory.

Compare variants

DataTable

Illustrative efficacy results from a fictional phase III cohort.
Endpoint	Treatment Arm	Comparator	Absolute Difference
Primary response at week 24	68%	49%	+19 pts
Sustained response at week 52	61%	44%	+17 pts
Patient-reported symptom score	-38%	-22%	-16 pts
Discontinuation due to AEs	4%	5%	-1 pt

ClaimReference

In this illustrative cohort, Apexa improved the primary response rate versus comparator at week 24.¹

Fictional Study AX-301; data on file for hackathon demonstration only.

ImageBlock

Illustrative molecular-style blue abstract background — Placeholder creative treatment showing how approved media surfaces are framed.

CTA

Primary action Secondary action Outline action

Disclaimer

ISIBlock

Important Safety Information

WARNING: This is demo-only safety content. In production, important safety information must be sourced from approved labeling, remain visible to the target audience, and preserve fair balance against efficacy messaging. Clinicians should review complete prescr...

Footer